Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
June 01 2022 - 05:19PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
OF THE SECURITIES EXCHANGE ACT OF 1934
For the month of June 2022
(Commission File No. 001-38547)
Autolus Therapeutics plc
(Translation of registrant’s name into
English)
The MediaWorks
191 Wood Lane
London W12 7FP
United Kingdom
(Address of registrant’s principal executive
office)
Indicate by check mark whether the registrant files or will file
annual reports under cover Form 20-F or Form 40-F.
Form 20-F ☒ Form
40-F ☐
Indicate by check mark if the registrant is submitting the Form
6-K in paper as permitted
by Regulation S-T Rule 101
(b) (1): ☐
Indicate by check mark if the registrant is submitting the Form
6-K in paper as permitted
by Regulation S-T Rule 101
(b) (7): ☐
Other Events
On May 31, 2022, Autolus Therapeutics plc (the “Company”)
published its 2021 UK Annual Report (the “UK Annual Report”) for
the year ended December 31, 2021 and distributed a notice of
its annual general meeting to be held on June 28, 2022 (the
“AGM”), a form of proxy and its UK Annual Report to its ordinary
shareholders. The notice of the AGM is attached as Exhibit 99.1
hereto. The UK Annual Report is posted on the investor relations
section of the Company’s website at www.autolus.com.
On or about May 31, 2022, Citibank, N.A., in its capacity as
the depositary bank (the “Depositary”) for the Company’s American
Depositary Shares (“ADSs”), commenced mailing notice materials and
voting cards to ADS holders to enable ADS holders of record as of
May 23, 2022 to instruct the Depositary to vote the ordinary
shares represented by their ADSs. If the Depositary receives timely
voting instructions from an ADS holder, it will endeavor to vote
the ordinary shares (in person or by proxy) represented by the
holder’s ADSs in accordance with the ADS holder’s voting
instructions. The ability of the Depositary to carry out voting
instructions may be limited by practical and legal limitations and
ADS holders may not receive voting materials in time to enable them
to return voting instructions to the Depositary in a timely manner.
The notice materials to be mailed by the Depositary to ADS holders
will contain a link to the Company’s website where ADS holders can
view and download the AGM notice distributed by the Company to its
ordinary shareholders (which contains explanatory notes for the
resolutions being voted on at the AGM) and the UK Annual
Report.
The information contained in Exhibit 99.1 or the UK Annual Report
shall not be deemed “filed” for purposes of Section 18 of the
Securities Exchange Act of 1934, as amended (the “Exchange Act”),
or incorporated by reference in any filing under the Securities Act
of 1933, as amended, or the Exchange Act, unless expressly set
forth by specific reference in such a filing.
Exhibits
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned, thereunto duly authorized.
|
|
|
Autolus Therapeutics plc |
|
|
By: |
|
/s/ Christian Itin
|
Name: |
|
Christian Itin |
Title: |
|
Chief Executive Officer |
Date: June 1, 2022
Autolus Therapeutics (NASDAQ:AUTL)
Historical Stock Chart
From Mar 2023 to Apr 2023
Autolus Therapeutics (NASDAQ:AUTL)
Historical Stock Chart
From Apr 2022 to Apr 2023